BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 33757653)

  • 1. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
    Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
    Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAX1 and SOX1 Gene Methylation as a Detection and Triage Method for Cervical Intraepithelial Neoplasia Diagnosis.
    Gao Y; Zi D; Liang W; Qiu F; Zheng J; Xiao X; Jiang E; Xu Y
    Acta Cytol; 2024; 68(2):137-144. PubMed ID: 38527422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
    Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
    J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the diagnostic performance of PAX1/SOX1 gene methylation in cervical precancerous lesions and its role in triage diagnosis.
    Fan C; Hu J; Luo T; Dong B; Li H; Wang W; Yan J; Cai H
    J Med Virol; 2024 May; 96(5):e29521. PubMed ID: 38727013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
    Hesselink AT; Heideman DA; Steenbergen RD; Coupé VM; Overmeer RM; Rijkaart D; Berkhof J; Meijer CJ; Snijders PJ
    Clin Cancer Res; 2011 Apr; 17(8):2459-65. PubMed ID: 21389098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping.
    Hernández-López R; Lorincz AT; Torres-Ibarra L; Reuter C; Scibior-Bentkowska D; Warman R; Nedjai B; Mendiola-Pastrana I; León-Maldonado L; Rivera-Paredez B; Ramírez-Palacios P; Lazcano-Ponce E; Cuzick J; Salmerón J;
    Clin Epigenetics; 2019 Oct; 11(1):140. PubMed ID: 31606044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).
    Luttmer R; De Strooper LM; Berkhof J; Snijders PJ; Dijkstra MG; Uijterwaal MH; Steenbergen RD; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; Van Baal WM; Graziosi PG; Quint WG; Heideman DA; Meijer CJ
    Int J Cancer; 2016 Feb; 138(4):992-1002. PubMed ID: 26317579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical performance of methylation as a biomarker for cervical carcinoma in situ and cancer diagnosis: A worldwide study.
    Banila C; Lorincz AT; Scibior-Bentkowska D; Clifford GM; Kumbi B; Beyene D; Wheeler CM; Cuschieri K; Cuzick J; Nedjai B
    Int J Cancer; 2022 Jan; 150(2):290-302. PubMed ID: 34562270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylated
    Su Y; Tang Y; Zhang T; Xu Y; Zhang Y; Shen Y; Qin L; Zhang L; Cao L; Zhou Y; Liou Y; Zhang M
    Future Oncol; 2022 Jul; 18(23):2583-2592. PubMed ID: 35758002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective methylation triage of HPV positive women with abnormal cytology in a middle-income country.
    Ramírez AT; Sánchez GI; Nedjai B; Agudelo MC; Brentnall AR; Cuschieri K; Castañeda KM; Cuzick J; Lorincz AT;
    Int J Cancer; 2021 Mar; 148(6):1383-1393. PubMed ID: 33006394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
    Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
    Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.
    Aoyama-Kikawa S; Fujita H; Hanley SJB; Kasamo M; Kikuchi K; Torigoe T; Matsuno Y; Tamakoshi A; Sasaki T; Matsuura M; Kato Y; Dong P; Watari H; Saito T; Sengoku K; Sakuragi N
    Cancer Sci; 2018 Jun; 109(6):2003-2012. PubMed ID: 29660849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness of HPV16 and HPV18 genotyping and cytology with different thresholds for the triage of human papillomavirus-based screening on self-collected samples.
    Song F; Du H; Wang C; Huang X; Wu R;
    PLoS One; 2020; 15(6):e0234518. PubMed ID: 32525936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation testing with S5 for triage of high-risk HPV positive women.
    Adcock R; Nedjai B; Lorincz AT; Scibior-Bentkowska D; Banwait R; Torrez-Martinez N; Robertson M; Cuzick J; Wheeler CM;
    Int J Cancer; 2022 Oct; 151(7):993-1004. PubMed ID: 35477862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining Optimal Triage Strategies for hrHPV Screen-Positive Women-An Evaluation of HPV 16/18 Genotyping, Cytology, and p16/Ki-67 Cytoimmunochemistry.
    Stanczuk GA; Baxter GJ; Currie H; Forson W; Lawrence JR; Cuschieri K; Wilson A; Patterson L; Govan L; Black J; Palmer T; Arbyn M
    Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1629-1635. PubMed ID: 28887297
    [No Abstract]   [Full Text] [Related]  

  • 17. Methylation marker analysis and HPV16/18 genotyping in high-risk HPV positive self-sampled specimens to identify women with high grade CIN or cervical cancer.
    Verhoef VM; Heideman DA; van Kemenade FJ; Rozendaal L; Bosgraaf RP; Hesselink AT; Bekkers RL; Massuger LF; Steenbergen RD; Snijders PJ; Berkhof J; Meijer CJ
    Gynecol Oncol; 2014 Oct; 135(1):58-63. PubMed ID: 25111387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX1 methylation as a robust predictor: developing and validating a nomogram for assessing endocervical curettage (ECC) necessity in human papillomavirus16/18-positive women undergoing colposcopy.
    Lu Y; Wu H; Fu K; Shen Y; Li L; Liao Z; Liu Y; Kang Y; Zhang Y
    Clin Epigenetics; 2024 Jun; 16(1):77. PubMed ID: 38849868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term prediction by DNA methylation of high-grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort.
    Gilham C; Nedjai B; Scibior-Bentkowska D; Reuter C; Banwait R; Brentnall AR; Cuzick J; Peto J; Lorincz AT
    Int J Cancer; 2024 Jul; 155(1):81-92. PubMed ID: 38507581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
    De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.